SEHK:867
SEHK:867Pharmaceuticals

Does MG-K10’s COPD Trial Approval Change the Bull Case for China Medical System Holdings (SEHK:867)?

On September 29, 2025, China Medical System Holdings announced that its innovative anti-IL-4Ra monoclonal antibody MG-K10 received regulatory approval from China's National Medical Products Administration to begin clinical trials for Chronic Obstructive Pulmonary Disease (COPD). This milestone not only expands the company’s respiratory pipeline, but also highlights MG-K10’s potential as the first long-acting anti-IL-4Ra antibody therapy for multiple type 2 inflammatory diseases. We will...
SEHK:291
SEHK:291Beverage

China Resources Beer (SEHK:291): Assessing Valuation Following Leadership Reshuffle

China Resources Beer (Holdings) (SEHK:291) has made sweeping changes to its leadership team, appointing Mr. Jin Hanquan as executive director and president, Mr. Li Nan as a non-executive director, and Ms. Yang Hongxia as chief financial officer. These moves could reshape the company’s operations and influence its market direction. See our latest analysis for China Resources Beer (Holdings). Fresh faces at the top may be stirring optimism around China Resources Beer, but the 1-day share price...
SEHK:10
SEHK:10Real Estate

What Hang Lung Group (SEHK:10)'s Golden Week Sales Surge Means For Shareholders

Hang Lung Properties announced strong operational results from its Chinese mainland and Hong Kong properties during the National Day Golden Week, including major sales and visitor increases, especially at Heartland 66, Grand Gateway 66, and Hong Kong’s Peak Galleria. Sales growth in mainland malls resumed in the third quarter, reversing earlier declines, highlighting the impact of flagship store openings and reinvigorated consumer activity. With tenant sales rebounding and new flagship...
SEHK:1093
SEHK:1093Pharmaceuticals

CSPC Pharmaceutical Group (SEHK:1093): Evaluating Valuation After a Strong Year for Shares

CSPC Pharmaceutical Group (SEHK:1093) shares climbed slightly today, closing at HK$9.53. Investors seem to be weighing the company's recent performance and healthy earnings momentum, particularly following a near 20% gain over the past 3 months. See our latest analysis for CSPC Pharmaceutical Group. After a year of impressive momentum, CSPC Pharmaceutical Group's share price has surged over 105% year-to-date. This growth has been supported by healthy fundamentals and positive sentiment...
SEHK:883
SEHK:883Oil and Gas

CNOOC (SEHK:883): Assessing Valuation as Shares Tick Higher on Steady Long-Term Growth

CNOOC (SEHK:883) shares saw a modest uptick on the Hong Kong exchange today. This has caught the attention of investors interested in how China’s energy sector stocks have been moving recently. Short-term returns remain muted, while longer-term performance is tracking higher. See our latest analysis for CNOOC. CNOOC’s share price hasn’t made dramatic moves recently, but momentum over the past year has remained steady, supported by a 1-year total shareholder return of nearly 1%. Long-term...
SEHK:2005
SEHK:2005Pharmaceuticals

Asian Penny Stock Opportunities For October 2025

As global markets grapple with renewed U.S.-China trade tensions and economic uncertainties, investors are increasingly exploring diverse opportunities in Asia. Penny stocks, often representing smaller or newer companies, remain an intriguing area despite the term's somewhat outdated connotations. By focusing on those with robust financials and potential for growth, investors can uncover hidden value in these less prominent yet promising companies.
SEHK:6699
SEHK:6699Medical Equipment

Angelalign Technology (SEHK:6699): Evaluating Valuation After Recent Share Price Decline

Angelalign Technology (SEHK:6699) shares have retreated roughly 2% after a challenging week, extending a downtrend that has lingered all month. Investors appear to be weighing recent returns against the company’s annual growth metrics. See our latest analysis for Angelalign Technology. Despite rallying earlier in the quarter, Angelalign Technology’s momentum has faded in recent weeks as the share price dipped 9.1% over the past month and the 1-year total shareholder return stands at -8.5%...
SEHK:1405
SEHK:1405Hospitality

Rapid Store Openings and Rising Digital Engagement Might Change The Case For Investing In DPC Dash (SEHK:1405)

DPC Dash, the exclusive master franchisee of Domino's Pizza in China, opened 275 net new stores in the Chinese Mainland during the third quarter of 2025, bringing its total to 1,283 stores across 51 cities as of September 30, 2025. A significant rise in loyalty program membership and positive same-store sales growth underscore the company's digital engagement and resilience in major urban markets. We'll examine how rapid expansion into new cities and rising digital engagement are shifting...